Adherence to Guidelines for Influenza, Pneumococcal and Hepatitis B Vaccination in Adult Patients With Type 1 Diabetes Mellitus (AVADI-1).
The AVADI-1 study, sponsored by Jesús Moreno Fernández and conducted at Ciudad Real General University Hospital, evaluated adherence to vaccination guidelines for Influenza, Pneumococcal, and Hepatitis B in adult patients with Type 1 Diabetes Mellitus. With a cohort of 300 participants, the study highlights the importance of vaccination in this high-risk population, potentially influencing public health policies and vaccination strategies. The findings may provide insights for pharmaceutical companies involved in vaccine development and distribution, particularly in targeting diabetes patients. The study's completion and data availability could enhance market positioning for companies focusing on diabetes care and preventive measures.
Indication: Type 1 Diabetes Mellitus
Modality: vaccine
Target: Not applicable (observational study)
Sponsor: Jesús Moreno Fernández
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 02, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Not applicable (observational study)
View original source fields
Condition raw: Type 1 Diabetes Mellitus
Condition normalized: Type 1 Diabetes Mellitus
Modality raw: vaccine
Modality normalized: vaccine
Target raw: Not applicable (observational study)
Target normalized: Not applicable (observational study)